SHP2 plays a significant role in bone development and cartilage homeostasis, influencing the transdifferentiation of hypertrophic chondrocytes into osteoblasts and providing insights into the pathogenesis and potential treatments for skeletal diseases, such as osteoporosis and osteopenia [25]. Here, PTPN11 is linked to osteoporosis.